[chamada] NIH – Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01)
Objetivo:
The purpose of this Funding Opportunity Announcement (FOA) is to support research that advances compounds towards FDA approval by leveraging NIDA funds with the strengths and resources of outside organizations, such as for-profit and not-for-profit entities, including academic institutions, pharmaceutical and biotechnology companies, private and public foundations, and small businesses.
Inscrições:
July 25, 2017; March 27, 2018; July 25, 2018; March 27, 2019; July 25,
2019.
Letter of Intent Due Date(s):
30 days prior to the application due date
Data de expiração:
July 26, 2019.
Mais informações no site.